FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
August 12, 2009Web posted by PAF
--
The U.S. Food and Drug Administration published two rules today that seek to clarify the methods available to seriously ill patients interested in gaining access to investigational drugs and biologics when they are not eligible to participate in a clinical trial and don’t have other satisfactory treatment options.
Read the complete press release from the FDA's website
